{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:46:29Z","timestamp":1791744389711,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While lifelong aspirin mono-therapy remains the standard of care following coronary artery bypass graft surgery (CABG), the optimal antiplatelet strategy remains a subject of ongoing debate. The evidence argues against a \u2018one-size-fits-all\u2019 strategy and supports a patient-centred approach. Antiplatelet treatment decisions should incorporate bleeding risk which is often multifactorial and necessitates careful individualised evaluation based on patient characteristics and procedural factors. Conduit selection should also be considered as graft failure following CABG remains an important problem and varies according to conduit type, highlighting the critical role of antiplatelet therapy. Saphenous vein grafts are particularly susceptible to early thrombosis and late atherosclerotic degeneration, making optimisation of antiplatelet therapy especially relevant for preserving vein graft patency, whereas its impact on arterial grafts is less well defined. Current guideline recommendations are largely extrapolated from studies involving patients with acute or chronic coronary syndromes treated with percutaneous intervention or medical therapy. Clinical presentation is also a key determinant of antiplatelet strategy. Although current guidelines support resumption of dual antiplatelet therapy (DAPT) after CABG in patients with acute coronary syndromes (ACS), these recommendations are largely inherited from CABG subgroups of broader ACS trials rather than dedicated CABG randomised studies, and recent CABG-specific evidence has challenged the routine use of ticagrelor-based DAPT in this setting. DAPT in chronic coronary syndromes may be considered only in selected patients at low bleeding risk. Although, observational and randomised data suggest that DAPT can improve vein graft patency, but this has not consistently translated into short-term clinical benefit and is offset by increased bleeding risk. In fact, emerging evidence suggests shorter or de-escalated DAPT strategies may offer a more favourable balance between graft protection and bleeding.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Patient-centred antiplatelet therapy post CABG. CABG \u2013 coronary artery bypass graft surgery; ACS \u2013 acute coronary syndrome; CCS \u2013 chronic coronary syndrome; SAPT \u2013 single anti-platelet therapy; DAPT \u2013 dual anti-platelet therapy.<\/jats:p>","DOI":"10.1007\/s11239-026-03331-2","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:10:54Z","timestamp":1780063854000},"page":"1728-1738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-centred anti-platelet therapy following coronary artery bypass graft surgery"],"prefix":"10.1007","volume":"59","author":[{"given":"Eleonora","family":"De Laurentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Sahdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Jahangiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"3331_CR1","doi-asserted-by":"publisher","unstructured":"Jeppsson A, (Co-Chairperson) (Sweden), Rocca B et al (2024) 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. European Journal of Cardio-Thoracic Surgery 67:ezae355. https:\/\/doi.org\/10.1093\/ejcts\/ezae355","DOI":"10.1093\/ejcts\/ezae355"},{"key":"3331_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/eurheartj\/ehab096","volume":"42","author":"M Gaudino","year":"2021","unstructured":"Gaudino M, Di Franco A, Bhatt DL et al (2021) The association between coronary graft patency and clinical status in patients with coronary artery disease. Eur Heart J 42:1433\u20131441. https:\/\/doi.org\/10.1093\/eurheartj\/ehab096","journal-title":"Eur Heart J"},{"key":"3331_CR3","doi-asserted-by":"publisher","unstructured":"SandnerS, Gaudino M, Agewall S et al (2025) Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 30:ehaf423 https:\/\/doi.org\/10.1093\/eurheartj\/ehaf423","DOI":"10.1093\/eurheartj\/ehaf423"},{"key":"3331_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa020798","volume":"347","author":"DT Mangano","year":"2002","unstructured":"Mangano DT, Multicenter Study of Perioperative Ischemia Research Group (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309\u20131317. https:\/\/doi.org\/10.1056\/NEJMoa020798","journal-title":"N Engl J Med"},{"key":"3331_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","volume":"73","author":"T Doenst","year":"2019","unstructured":"Doenst T, Haverich A, Serruys P et al (2019) PCI and CABG for Treating Stable Coronary Artery Disease. J Am Coll Cardiol 73:964\u2013976. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.053","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/CIRCULATIONAHA.123.064090","volume":"148","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Sandner S, An KR et al (2023) Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up. Circulation 148:1305\u20131315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064090","journal-title":"Circulation"},{"key":"3331_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","volume":"28","author":"GM Fitzgibbon","year":"1996","unstructured":"Fitzgibbon GM, Kafka HP, Leach AJ et al (1996) Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616\u2013626. https:\/\/doi.org\/10.1016\/0735-1097(96)00206-9","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jacc.2012.03.037","volume":"60","author":"S Deb","year":"2012","unstructured":"Deb S, Cohen EA, Singh SK et al (2012) Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 60:28\u201335. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.037","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR9","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","volume":"44","author":"S Goldman","year":"2004","unstructured":"Goldman S, Zadina K, Moritz T et al (2004) Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 44:2149\u20132156. https:\/\/doi.org\/10.1016\/j.jacc.2004.08.064","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jtcvs.2022.08.047","volume":"167","author":"J Ren","year":"2024","unstructured":"Ren J, Royse C, Siderakis C et al (2024) Long-term observational angiographic patency and perfect patency of radial artery compared with saphenous vein or internal mammary artery in coronary bypass surgery. J Thorac Cardiovasc Surg 167:1293\u20131302e4. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.08.047","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3331_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11239-023-02940-5","volume":"57","author":"MS Mauro","year":"2024","unstructured":"Mauro MS, Finocchiaro S, Calderone D et al (2024) Antithrombotic strategies for preventing graft failure in coronary artery bypass graft. J Thromb Thrombolysis 57:547\u2013557. https:\/\/doi.org\/10.1007\/s11239-023-02940-5","journal-title":"J Thromb Thrombolysis"},{"key":"3331_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.119.045427","volume":"142","author":"BF Buxton","year":"2020","unstructured":"Buxton BF, Hayward PA, Raman J et al (2020) Long-Term Results of the RAPCO Trials. Circulation 142:1330\u20131338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.045427","journal-title":"Circulation"},{"key":"3331_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/eurheartj\/ehae654","volume":"46","author":"S Sandner","year":"2025","unstructured":"Sandner S, Antoniades C, Caliskan E et al (2025) Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoracic Surgery Coronary Task Force. Eur Heart J 46:19\u201334. https:\/\/doi.org\/10.1093\/eurheartj\/ehae654","journal-title":"Eur Heart J"},{"key":"3331_CR14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.cir.101.10.1206","volume":"101","author":"EH Awtry","year":"2000","unstructured":"Awtry EH, Loscalzo J (2000) Aspirin Circulation 101:1206\u20131218. https:\/\/doi.org\/10.1161\/01.cir.101.10.1206","journal-title":"Aspirin Circulation"},{"key":"3331_CR15","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1161\/CIR.0000000000001039","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S et al (2022) 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:e4\u2013e17. https:\/\/doi.org\/10.1161\/CIR.0000000000001039","journal-title":"Circulation"},{"key":"3331_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ejcts\/ezy289","volume":"55","author":"M Sousa-Uva","year":"2019","unstructured":"Sousa-Uva M, Neumann F-J, Ahlsson A et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 55:4\u201390. https:\/\/doi.org\/10.1093\/ejcts\/ezy289","journal-title":"Eur J Cardiothorac Surg"},{"key":"3331_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2014.156","volume":"12","author":"F Franchi","year":"2015","unstructured":"Franchi F, Angiolillo DJ (2015) Novel antiplatelet agents in acute coronary syndrome. Nat Rev Cardiol 12:30\u201347. https:\/\/doi.org\/10.1038\/nrcardio.2014.156","journal-title":"Nat Rev Cardiol"},{"key":"3331_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"key":"3331_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","volume":"60","author":"PK Smith","year":"2012","unstructured":"Smith PK, Goodnough LT, Levy JH et al (2012) Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol 60:388\u2013396. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.030","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","volume":"57","author":"C Held","year":"2011","unstructured":"Held C, Asenblad N, Bassand JP et al (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 57:672\u2013684. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.029","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.hjc.2018.06.012","volume":"60","author":"LCS Res","year":"2019","unstructured":"Res LCS, Lubberts B, Shah SH, DiGiovanni CW (2019) Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy - A systematic review. Hellenic J Cardiol 60:3\u201310. https:\/\/doi.org\/10.1016\/j.hjc.2018.06.012","journal-title":"Hellenic J Cardiol"},{"key":"3331_CR22","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.21037\/jtd-21-1241","volume":"13","author":"T Senage","year":"2021","unstructured":"Senage T, Gerrard C, Moorjani N et al (2021) Early postoperative bleeding impacts long-term survival following first-time on-pump coronary artery bypass grafting. J Thorac Dis 13:5670\u20135682. https:\/\/doi.org\/10.21037\/jtd-21-1241","journal-title":"J Thorac Dis"},{"key":"3331_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3109\/09537104.2016.1173665","volume":"27","author":"S Van Poucke","year":"2016","unstructured":"Van Poucke S, Stevens K, Wetzels R et al (2016) Early platelet recovery following cardiac surgery with cardiopulmonary bypass. Platelets 27:751\u2013757. https:\/\/doi.org\/10.3109\/09537104.2016.1173665","journal-title":"Platelets"},{"key":"3331_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.athoracsur.2004.02.088","volume":"78","author":"S Karthik","year":"2004","unstructured":"Karthik S, Grayson AD, McCarron EE et al (2004) Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 78:527\u2013534 discussion 534. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.02.088","journal-title":"Ann Thorac Surg"},{"key":"3331_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCOUTCOMES.109.858811","volume":"2","author":"RH Mehta","year":"2009","unstructured":"Mehta RH, Sheng S, O\u2019Brien SM et al (2009) Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2:583\u2013590. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.109.858811","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3331_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","volume":"389","author":"F Costa","year":"2017","unstructured":"Costa F, van Klaveren D, James S et al (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389:1025\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(17)30397-5","journal-title":"Lancet"},{"key":"3331_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ehjcvp\/pvae060","volume":"11","author":"P Enstr\u00f6m","year":"2025","unstructured":"Enstr\u00f6m P, Martinsson A, Rezk M et al (2025) The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding. Eur Heart J Cardiovasc Pharmacother 11:48\u201356. https:\/\/doi.org\/10.1093\/ehjcvp\/pvae060","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3331_CR28","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J 40:2632\u20132653. https:\/\/doi.org\/10.1093\/eurheartj\/ehz372","journal-title":"Eur Heart J"},{"key":"3331_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.ejcts.2010.10.003","volume":"39","author":"A Vuylsteke","year":"2011","unstructured":"Vuylsteke A, Pagel C, Gerrard C et al (2011) The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 39:924\u2013930. https:\/\/doi.org\/10.1016\/j.ejcts.2010.10.003","journal-title":"Eur J Cardiothorac Surg"},{"key":"3331_CR30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1537-2995.2006.00860.x","volume":"46","author":"AA Alghamdi","year":"2006","unstructured":"Alghamdi AA, Davis A, Brister S et al (2006) Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion 46:1120\u20131129. https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00860.x","journal-title":"Transfusion"},{"key":"3331_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1160\/TH16-09-0721","volume":"117","author":"F Biancari","year":"2017","unstructured":"Biancari F, Brascia D, Onorati F et al (2017) Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score. Thromb Haemost 117:445\u2013456. https:\/\/doi.org\/10.1160\/TH16-09-0721","journal-title":"Thromb Haemost"},{"key":"3331_CR32","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.athoracsur.2015.10.028","volume":"101","author":"G Mariscalco","year":"2016","unstructured":"Mariscalco G, Gherli R, Ahmed AB et al (2016) Validation of the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) Bleeding Severity Definition. Ann Thorac Surg 101:1782\u20131788. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.10.028","journal-title":"Ann Thorac Surg"},{"key":"3331_CR33","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jtcvs.2013.10.070","volume":"147","author":"C Dyke","year":"2014","unstructured":"Dyke C, Aronson S, Dietrich W et al (2014) Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 147:1458\u20131463e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.10.070","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3331_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/VHRM.S44469","volume":"11","author":"R Paniccia","year":"2015","unstructured":"Paniccia R, Priora R, Liotta AA, Abbate R (2015) Platelet function tests: a comparative review. Vasc Health Risk Manag 11:133\u2013148. https:\/\/doi.org\/10.2147\/VHRM.S44469","journal-title":"Vasc Health Risk Manag"},{"key":"3331_CR35","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.118.035160","volume":"138","author":"E Mahla","year":"2018","unstructured":"Mahla E, Tantry US, Pr\u00fcller F, Gurbel PA (2018) Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy? Circulation 138:2145\u20132159. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035160","journal-title":"Circulation"},{"key":"3331_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/ejcts\/ezx181","volume":"52","author":"A Della Corte","year":"2017","unstructured":"Della Corte A, Bancone C, Spadafora A et al (2017) Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry. Eur J Cardiothorac Surg 52:901\u2013908. https:\/\/doi.org\/10.1093\/ejcts\/ezx181","journal-title":"Eur J Cardiothorac Surg"},{"key":"3331_CR37","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.athoracsur.2016.05.003","volume":"102","author":"E Mahla","year":"2016","unstructured":"Mahla E, Prueller F, Farzi S et al (2016) Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy? Ann Thorac Surg 102:2010\u20132017. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.05.003","journal-title":"Ann Thorac Surg"},{"key":"3331_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/anae.13083","volume":"70","author":"C Corredor","year":"2015","unstructured":"Corredor C, Wasowicz M, Karkouti K, Sharma V (2015) The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis. Anaesthesia 70:715\u2013731. https:\/\/doi.org\/10.1111\/anae.13083","journal-title":"Anaesthesia"},{"key":"3331_CR39","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/09537104.2018.1535706","volume":"30","author":"M Ranucci","year":"2019","unstructured":"Ranucci M, Pistuddi V, Di Dedda U et al (2019) Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study. Platelets 30:908\u2013914. https:\/\/doi.org\/10.1080\/09537104.2018.1535706","journal-title":"Platelets"},{"key":"3331_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ehjcvp\/pvz059","volume":"6","author":"Y-Y Zheng","year":"2020","unstructured":"Zheng Y-Y, Wu T-T, Yang Y et al (2020) Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial. Eur Heart J Cardiovasc Pharmacother 6:211\u2013221. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz059","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3331_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","volume":"390","author":"D Sibbing","year":"2017","unstructured":"Sibbing D, Aradi D, Jacobshagen C et al (2017) Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet 390:1747\u20131757. https:\/\/doi.org\/10.1016\/S0140-6736(17)32155-4","journal-title":"Lancet"},{"key":"3331_CR42","doi-asserted-by":"publisher","first-page":"e007811","DOI":"10.1161\/CIRCINTERVENTIONS.119.007811","volume":"12","author":"NL Pereira","year":"2019","unstructured":"Pereira NL, Rihal CS, So D et al (2019) Clopidogrel Pharmacogenetics: State of the Art Review and the TAILOR-PCI Study. Circ Cardiovasc Interv 12:e007811. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.007811","journal-title":"Circ Cardiovasc Interv"},{"key":"3331_CR43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","volume":"18","author":"JD Duarte","year":"2021","unstructured":"Duarte JD, Cavallari LH (2021) Pharmacogenetics to guide cardiovascular drug therapy. Nat Rev Cardiol 18:649\u2013665. https:\/\/doi.org\/10.1038\/s41569-021-00549-w","journal-title":"Nat Rev Cardiol"},{"key":"3331_CR44","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","volume":"381","author":"DMF Claassens","year":"2019","unstructured":"Claassens DMF, Vos GJA, Bergmeijer TO et al (2019) A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. N Engl J Med 381:1621\u20131631. https:\/\/doi.org\/10.1056\/NEJMoa1907096","journal-title":"N Engl J Med"},{"key":"3331_CR45","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 45:3415\u20133537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177","journal-title":"Eur Heart J"},{"key":"3331_CR46","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44:3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"3331_CR47","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Collaboration, Baigent","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT), Collaboration, Baigent C, Blackwell L et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849\u20131860. https:\/\/doi.org\/10.1016\/S0140-6736(09)60503-1","journal-title":"Lancet"},{"key":"3331_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386. https:\/\/doi.org\/10.1136\/bmj.324.7329.71","journal-title":"BMJ"},{"key":"3331_CR49","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","volume":"41","author":"E Bj\u00f6rklund","year":"2020","unstructured":"Bj\u00f6rklund E, Nielsen SJ, Hansson EC et al (2020) Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry. Eur Heart J 41:1653\u20131661. https:\/\/doi.org\/10.1093\/eurheartj\/ehz714","journal-title":"Eur Heart J"},{"key":"3331_CR50","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/s0140-6736(84)92446-2","volume":"1","author":"RL Lorenz","year":"1984","unstructured":"Lorenz RL, Schacky CV, Weber M et al (1984) Improved aortocoronary bypass patency by low-dose aspirin (100\u00a0mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1:1261\u20131264. https:\/\/doi.org\/10.1016\/s0140-6736(84)92446-2","journal-title":"Lancet"},{"key":"3331_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","volume":"7","author":"SE Fremes","year":"1993","unstructured":"Fremes SE, Levinton C, Naylor CD et al (1993) Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg 7:169\u2013180. https:\/\/doi.org\/10.1016\/1010-7940(93)90155-5","journal-title":"Eur J Cardiothorac Surg"},{"key":"3331_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1569-9293(03)00181-6","volume":"2","author":"G Musleh","year":"2003","unstructured":"Musleh G, Dunning J (2003) Does aspirin 6\u00a0h after coronary artery bypass grafting optimise graft patency? Interact Cardiovasc Thorac Surg 2:413\u2013415. https:\/\/doi.org\/10.1016\/S1569-9293(03)00181-6","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3331_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.athoracsur.2009.04.024","volume":"88","author":"C Gao","year":"2009","unstructured":"Gao C, Ren C, Li D, Li L (2009) Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg 88:59\u201362. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.04.024","journal-title":"Ann Thorac Surg"},{"key":"3331_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/jocs.16189","volume":"37","author":"A Kulik","year":"2022","unstructured":"Kulik A, Abreu AM, Boronat V et al (2022) Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial. J Card Surg 37:563\u2013570. https:\/\/doi.org\/10.1111\/jocs.16189","journal-title":"J Card Surg"},{"key":"3331_CR55","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.2022.11966","volume":"328","author":"S Sandner","year":"2022","unstructured":"Sandner S, Redfors B, Angiolillo DJ et al (2022) Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis. JAMA 328:554\u2013562. https:\/\/doi.org\/10.1001\/jama.2022.11966","journal-title":"JAMA"},{"key":"3331_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa010746","journal-title":"N Engl J Med"},{"key":"3331_CR57","doi-asserted-by":"publisher","first-page":"l5476","DOI":"10.1136\/bmj.l5476","volume":"367","author":"K Solo","year":"2019","unstructured":"Solo K, Lavi S, Kabali C et al (2019) Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ 367:l5476. https:\/\/doi.org\/10.1136\/bmj.l5476","journal-title":"BMJ"},{"key":"3331_CR58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","volume":"110","author":"KAA Fox","year":"2004","unstructured":"Fox KAA, Mehta SR, Peters R et al (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110:1202\u20131208. https:\/\/doi.org\/10.1161\/01.CIR.0000140675.85342.1B","journal-title":"Circulation"},{"key":"3331_CR59","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa2508026","volume":"393","author":"A Jeppsson","year":"2025","unstructured":"Jeppsson A, James S, Moller CH et al (2025) Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome. N Engl J Med 393:2313\u20132323. https:\/\/doi.org\/10.1056\/NEJMoa2508026","journal-title":"N Engl J Med"},{"key":"3331_CR60","doi-asserted-by":"publisher","first-page":"e070823","DOI":"10.1136\/bmjopen-2022-070823","volume":"13","author":"X Yuan","year":"2023","unstructured":"Yuan X, Chu Q, Chen K et al (2023) Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study. BMJ Open 13:e070823. https:\/\/doi.org\/10.1136\/bmjopen-2022-070823","journal-title":"BMJ Open"},{"key":"3331_CR61","doi-asserted-by":"publisher","first-page":"e075707","DOI":"10.1136\/bmj-2023-075707","volume":"385","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhang W, Dimagli A et al (2024) Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ 385:e075707. https:\/\/doi.org\/10.1136\/bmj-2023-075707","journal-title":"BMJ"},{"key":"3331_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jacc.2018.10.048","volume":"73","author":"A Lamy","year":"2019","unstructured":"Lamy A, Eikelboom J, Sheth T et al (2019) Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study. J Am Coll Cardiol 73:121\u2013130. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.048","journal-title":"J Am Coll Cardiol"},{"key":"3331_CR63","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV et al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45:3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03331-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:36:57Z","timestamp":1791743817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03331-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3331"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03331-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}